Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
News + Filings
Transactions
KISHBAUCH MICHAEL D
Date
Name
Symbol
Type
Security
Shares
Price
Value
Ownership
Reported
06/09/2022
Astria Therapeutics, Inc.
ATXS
Grant
Stock Option (right to buy)
8.3k
$2.99
$24.9k
06/09/2022
06/09/2022
Astria Therapeutics, Inc.
ATXS
Grant
Stock Option (right to buy)
8.3k
$0.00
$0
06/09/2022
06/02/2021
Astria Therapeutics, Inc.
ATXS
Grant
Stock Option (right to buy)
100k
$2.04
$204k
06/02/2021
06/11/2020
Astria Therapeutics, Inc.
ATXS
Grant
Stock Option (right to buy)
7.5k
$6.17
$46.3k
06/11/2020
01/28/2020
ACHILLION PHARMACEUTICALS INC
ACHN
Disposition
Stock Options (Right to buy)
30k
$7.54
$226.2k
01/28/2020
01/28/2020
ACHILLION PHARMACEUTICALS INC
ACHN
Disposition
Stock Options (Right to buy)
30k
$4.09
$122.7k
01/28/2020
01/28/2020
ACHILLION PHARMACEUTICALS INC
ACHN
Disposition
Stock Options (Right to buy)
25k
$3.02
$75.5k
01/28/2020
01/28/2020
ACHILLION PHARMACEUTICALS INC
ACHN
Disposition
Stock Options (Right to buy)
30k
$2.90
$87k
01/28/2020
01/28/2020
ACHILLION PHARMACEUTICALS INC
ACHN
Disposition
Stock Options (Right to buy)
6.2k
$2.74
$17.1k
01/28/2020
01/28/2020
ACHILLION PHARMACEUTICALS INC
ACHN
Disposition
Stock Options (Right to buy)
42k
$2.18
$91.6k
01/28/2020
07/11/2019
PROGENICS PHARMACEUTICALS INC
PGNX
Grant
Non-Qualified Stock Option (Right to Buy)
25k
$5.74
$143.5k
07/11/2019
06/04/2019
Astria Therapeutics, Inc.
ATXS
Grant
Stock Option (right to buy)
7.5k
$6.53
$49k
06/04/2019
01/23/2019
ACHILLION PHARMACEUTICALS INC
ACHN
Grant
Stock Option (Right to buy)
42k
$2.18
$91.6k
01/23/2019
06/13/2018
PROGENICS PHARMACEUTICALS INC
PGNX
Grant
Non-Qualified Stock Option (Right to Buy)
25k
$8.99
$224.8k
06/13/2018
06/07/2018
Astria Therapeutics, Inc.
ATXS
Grant
Stock Option (right to buy)
14k
$1.48
$20.7k
06/07/2018
02/09/2018
ACHILLION PHARMACEUTICALS INC
ACHN
Grant
Employee Stock Option
30k
$2.90
$87k
02/09/2018
07/27/2017
Astria Therapeutics, Inc.
ATXS
Grant
Stock Option (right to buy)
6.5k
$1.27
$8.3k
07/27/2017
06/14/2017
PROGENICS PHARMACEUTICALS INC
PGNX
Grant
Non-Qualified Stock Option (Right to Buy)
20k
$6.95
$139k
06/14/2017
01/19/2017
ACHILLION PHARMACEUTICALS INC
ACHN
Grant
Employee Stock Option
30k
$4.09
$122.7k
01/19/2017
06/08/2016
PROGENICS PHARMACEUTICALS INC
PGNX
Grant
Non-Qualified Stock Option (Right to Buy)
20k
$4.89
$97.8k
06/08/2016
04/05/2016
Astria Therapeutics, Inc.
ATXS
Grant
Stock Option (right to buy)
13k
$4.80
$62.4k
04/05/2016
01/28/2015
TETRALOGIC PHARMACEUTICALS Corp
TLOG
Grant
Stock Option
10k
$5.25
$52.5k
01/28/2015
11/05/2014
TETRALOGIC PHARMACEUTICALS Corp
TLOG
Grant
Stock Options (right to buy)
20k
$3.87
$77.4k
11/05/2014
08/15/2014
ACHILLION PHARMACEUTICALS INC
ACHN
Exercise
Employee Stock Option (Right to Buy)
54.7k
$7.59
$415.1k
08/15/2014
08/15/2014
ACHILLION PHARMACEUTICALS INC
ACHN
Exercise
Employee Stock Option (Right to Buy)
133.1k
$3.28
$436.6k
08/15/2014
08/15/2014
ACHILLION PHARMACEUTICALS INC
ACHN
Exercise
Employee Stock Option (Right to Buy)
158k
$1.05
$165.9k
08/15/2014
08/15/2014
ACHILLION PHARMACEUTICALS INC
ACHN
Exercise
Employee Stock Option (Right to Buy)
150k
$4.82
$723k
08/15/2014
08/15/2014
ACHILLION PHARMACEUTICALS INC
ACHN
Sale
Common Stock
54.7k
$9.75
$533.2k
08/15/2014
08/15/2014
ACHILLION PHARMACEUTICALS INC
ACHN
Sale
Common Stock
133.1k
$9.36
$1.2M
08/15/2014
08/15/2014
ACHILLION PHARMACEUTICALS INC
ACHN
Sale
Common Stock
158k
$9.36
$1.5M
08/15/2014
08/15/2014
ACHILLION PHARMACEUTICALS INC
ACHN
Sale
Common Stock
150k
$9.36
$1.4M
08/15/2014
06/10/2014
ACHILLION PHARMACEUTICALS INC
ACHN
Exercise
Employee Stock Option (Right to Buy)
371.9k
$3.10
$1.2M
06/10/2014
06/10/2014
ACHILLION PHARMACEUTICALS INC
ACHN
Sale
Common Stock
371.9k
$7.75
$2.9M
06/10/2014
12/17/2013
ACHILLION PHARMACEUTICALS INC
ACHN
Grant
Stock Option (Right to Buy)
25k
$3.02
$75.5k
12/17/2013
01/11/2012
ACHILLION PHARMACEUTICALS INC
ACHN
Exercise
Employee Stock Option (Right to Buy)
8.9k
$1.60
$14.2k
01/10/2012
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy